WuXi Biologics Acquires Bayer Manufacturing Site in Germany
WuXi Biologics and Bayer have jointly announced an acquisition agreement that WuXi Biologics Germany GmbH will take over the operations of one of Bayer's final drug product manufacturing plants in Leverkusen, Germany, and purchase the associated equipment, in combination with a long-term lease contract for the building. Based on a manufacturing agreement to be negotiated, the plant would be operated by WuXi Biologics and serve as a back-up site for the final product manufacturing of Kovaltry™, an antihemophilic factor (recombinant). The transaction is expected to be concluded in the coming months subject to the satisfaction of customary closing conditions. Financial details were not disclosed.Learn More
This story first appeared without the correct text, it has since been corrected to reflect the headline. Our apologies for any confusion.
Federal Court Upholds Ruling Invalidating Genentech's U.S. Patent for Reducing Protein A Leaching During Affinity Chromatography
The Federal Circuit Court of the United States has affirmed the invalidation of Genentech's claims to methods for reducing Protein A leaching in affinity column chromatography in purifying monoclonal antibodies. This ruling comes after Genentech had appealed an earlier ruling by the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office invalidating its Patent No.
7,807,799. All of which stems from an earlier request by Hospira for an inter partes review of the patent in question arguing anticipation and obviousness. Legal analysts are citing the ruling as yet another example of the higher courts deference to the U.S. Patent and Trademark Office.
Just-Evotec Building Late Stage Biologics Manufacturing Facility in Washington State
Just - Evotec Biologics has initiated construction of a 130,000 sq. ft. late-stage clinical and commercial manufacturing facility for biologics in Redmond, Washington. Construction on the greenfield site, located in Redmond Ridge Business Park, is expected to be completed by late 2020 and operational in the first quarter of 2021. The facility will contain manufacturing pods for implementing intensified fed-batch or continuous processing up to 1,000 L scale, with the capability of manufacturing metric tons of drug substance. Also included are supporting quality labs and process development labs.
On this Day Alert
1953 Corvette Unveiled at GM Motorama
On this day in 1953, a prototype Chevrolet Corvette sports car makes its debut at General Motors' (GM) Motorama auto show at the Waldorf-Astoria Hotel in New York City. The Corvette, named for a fast type of naval warship, would eventually become an iconic American muscle car and remains in production today. Learn More
What Your Breath Could Reveal About Your Health
There's no better way to stop a disease than to catch and treat it early, before symptoms occur. That's the whole point of medical screening techniques like radiography, MRIs and blood tests. But there's one medium with overlooked potential for medical analysis: your breath. Technologist Julian Burschka shares the latest in the science of breath analysis -- the screening of the volatile organic compounds in your exhaled breath -- and how it could be used as a powerful tool to detect, predict and ultimately prevent disease. Learn More
If given the opportunity, would you want to go on the game show Jeopardy?